Abstract
Transcriptional activity is closely associated with DNA methylation and chromatin remodelling. Evidence is emerging that a family of methylation specific (methyl-CpG binding domain, MBD) proteins have the capacity to bind to methylated sequences and repress transcription. Recent advances in this area reveal that many of the MBD proteins are associated with histone deacetylase (HDAC) dependant repression. The capacity of MBD association to repress transcription would largely be defined by promoter structure and this is best explained by the position and density of DNA methylation. The mechanism of specific targeting of MBD family members to methylated sequences remains largely unknown. In order to understand the mechanistic details of silencing the current challenge is to identify and map these molecular determinants assembled on native chromatin in model systems of human development and disease. Downstream targets such as the methylated Fragile X Mental Retardation gene 1 (FMR1) gene and tumour suppressor genes are likely candidates. In this article, we describe a powerful strategy that involves the immunoprecipitation of in vivo formaldehyde fixed chromatin to identify MBD binding complexes directly isolated from the natural chromosomal environment. We demonstrate the methylated human Multidrug Resistance gene 1 (MDR1) is enriched with transcriptional repressors that belong to the MBD family and this would account for transcriptional silencing.
Similar content being viewed by others
References
El-Osta A & Wolffe AP (2000) Gene Expr. 9: 63–75
Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J & Wolffe AP (1998) Nat. Genet. 19: 187–191
Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN & Bird A (1998) Nature 393: 386–389
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U & Zoghbi HY (1999) Nat. Genet. 23: 185–188
Xiang F, Buervenich S, Nicolao P, Bailey ME, Zhang Z & Anvret M (2000) J. Med. Genet. 37: 250–255
Chen RZ, Akbarian S, Tudor M & Jaenisch R (2001) Nat. Genet. 27: 327–331
Guy J, Hendrich B, Holmes M, Martin JE & Bird A (2001) Nat. Genet. 27: 322–326
Nan X, Campoy J & Bird A (1997) Cell 88: 471–481
Hendrich B & Bird A (1998) Mol. Cell. Biol. 18: 6538–6547
Wade PA (2001) Oncogene 20: 3166–3173
Coffee B, Zhang F, Warren ST & Reines D (1999) Nat. Genet. 22: 98–101
Magdinier F & Wolffe AP (2001) Proc. Natl. Acad. Sci. USA 98: 4990–4995
El-Osta A, Kantharidis P, Zalcberg JR & Wolffe AP (2002) Mol. Cell Biol. 22: 1844–1857
Braunstein M, Rose AB, Holmes SG, Allis CD & Broach JR (1993) Genes. Dev. 7: 592–604
Zalcberg JR, Hu X F, Wall DM, Mirski S, Cole S, Nadalin G, De Luise M, Parkin JD, Vrazas V, Campbell L & Kantharidis P (1994) Int. J. Cancer. 57: 522–528
El-Osta A, Kantharidis P & Zalcberg J (1999) Biotechniques 26: 1114–1124
Kantharidis P, El-Osta A, deSilva M, Wall DM, Hu XF, Slater A, Nadalin G, Parkin JD & Zalcberg JR (1997) Clin. Cancer Res. 3: 2025–2032
Leegwater PA, De Abreu RA & Albertioni F (1998) Cancer Lett. 130: 169–173
Riccio A, Aaltonen LA, Godwin AK, Loukola A, Percesepe A, Salovaara R et al. (1999) Nat. Genet. 23: 266–268
Ng HH, Zhang Y, Hendrich B, Johnson CA, Turner BM, Erdjument-Bromage H, Tempst P, Reinberg D & Bird A (1999) Nat. Genet. 23: 58–61
Ng HH, Jeppesen P & Bird A (2000) Mol. Cell Biol. 20: 1394–1406
Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F & Wolffe AP (1999) Nat. Genet. 1: 62–66
Nguyen CT, Gonzales FA & Jones PA (2001) Nucleic Acids Res. 29: 4598–4606
Gregory RI, Randall TE, Johnson CA, Khosla S, Hatada I, O'Neill LP, Turner BM & Feil R (2001) Mol. Cell Biol. 21: 5426–5436
Lorincz MC, Schubeler D & Groudine M (2001) Mol. Cell Biol. 21: 7913–7922
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
El-Osta, A., Baker, E.K. & Wolffe, A.P. Profiling methyl-CpG specific determinants on transcriptionally silent chromatin. Mol Biol Rep 28, 209–215 (2001). https://doi.org/10.1023/A:1015744625049
Issue Date:
DOI: https://doi.org/10.1023/A:1015744625049